Human T-cell lymphotropic virus type 1 provirus and phylogenetic analysis in patients with mycosis fungoides and their family relatives
- 25 April 2006
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 155 (2), 372-378
- https://doi.org/10.1111/j.1365-2133.2006.07312.x
Abstract
Mycosis fungoides (MF) is a cutaneous T-cell lymphoma of unknown aetiology. A pathogenic role of human T-cell lymphotropic virus type 1 (HTLV-1) has been suggested but remains controversial. To determine whether MF is linked to HTLV-1.Blood samples were collected from 60 patients, 15 family relatives of patients with MF (MFRs), 20 healthy controls and 10 patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). The presence of HTLV-1 antibodies in serum was tested by the Western blot rp21e-enhanced test. DNA was extracted from the blood with the Qiagen blood kit. We used 500 ng of DNA either in conventional HTLV-1-specific polymerase chain reaction (PCR) or in real-time PCR using primers sk43 and sk44 together with a tax-specific fluorescent probe.In Western blot, antibodies against three to four HTLV-1 antigens were detected in 52% of patients with MF. All of the patients with HAM/TSP were positive, while only 7% of the MFRs and none of the 20 healthy controls reacted with HTLV-1 antigens in Western blot. One of 60 patients with MF and one of 15 MFRs were positive in HTLV-1 PCR. These two PCR-positive samples which were quantified in real-time PCR showed that fewer than five in 10(6) cells were HTLV-1 infected. We succeeded in amplifying and sequencing the 5' end of the provirus from the blood of the PCR-positive MFR by seminested PCR. A positive result was also obtained in this test. Phylogenetic tree analyses revealed a high homology of this sequence with other HTLV-1 sequences from the Middle East. The above PCR-positive MFR was the brother of a PCR-negative patient with MF.These findings demonstrate that HTLV-1 is probably not the aetiological agent of MF. However, it may play a role in immunosuppression and in the spreading of the disease.This publication has 19 references indexed in Scilit:
- Ethnic cluster of HTLV-I infection in Israel among the Mashhadi Jewish populationJournal of Medical Virology, 1998
- The Epidemiology of HTLV-I in EuropeJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Analysis of anti‐tax antibody of HTLV‐I carriers in an endemic area in JapanInternational Journal of Cancer, 1993
- Immune Responsiveness to the Immunodominant Recombinant Envelope Epitopes of Human T Lymphotropic Virus Types I and II in Diverse Geographic PopulationsThe Journal of Infectious Diseases, 1992
- HTLV-I infection and neurological disease in Rio de Janeiro.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Serological and molecular survey for HTLV-I infection in a high-risk Middle Eastern groupThe Lancet, 1990
- Chronic progressive myelopathy associated with elevated antibodies to human T‐lymphotropic virus type I and adult T‐cell leukemialike cellsAnnals of Neurology, 1987
- ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESISThe Lancet, 1985
- Human T-Cell Leukemia Virus (HTLV-I) Antibodies in AfricaScience, 1984
- Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProceedings of the National Academy of Sciences of the United States of America, 1980